Merger Arbitrage Tool

Filter by Deal Type:

Note: Premium members can sort this table by Profit, Annualized Profit and Closing Date.

  Symbol Announced Date Acquiring
Company
Deal
Type
Clo.
Value
Clo.
Price
Last
Price
Volume Optionable Div. Yield Clo.
Date
Profit Annu.
Profit
AKRX chart 04/24/2017 Fresenius Kabi (N/A) Cash $4.75 billion $34.00 $18.99 2,252,023 Yes N/A 09/30/2018 79.04% 670.93%
Akorn, Inc. merger details:

Expected to close by early 2018 for a closing value of $4.75 billion. Upon completion of the merger, shareholders of Akorn will receive $34.00 per share in cash.

Update(s)

July 19, 2017: Akorn (AKRX) announced that its shareholders, at a special meeting, have overwhelmingly voted to approve the previously announced merger agreement providing for the acquisition of Akorn by Fresenius Kabi.

February 27, 2018: According to Reuters, German healthcare group Fresenius SE has raised doubts about its planned acquisition of Akorn (AKRX) because of a probe into data integrity at the U.S. maker of liquid generic drugs.

March 31, 2018: In Akorn's (AKRX) 10K filed on February 28, 2018, it is mentioned that the merger may not be completed in a timely manner or at all. Since the deal did not close as scheduled on March 31, 2018, we have extended the closing date for this deal to April 30, 2018.

April 22, 2018: According to Bloomberg, Fresenius SE said it’s terminating the acquisition of Akorn (AKRX) after finding what it calls data-integrity issues at the U.S.-based generic-drug company.

April 23, 2018: Akorn (AKRX) filed a complaint in Delaware Chancery Court asking that Fresenius Kabi AG be required to fulfill its obligations under the definitive merger agreement.

May 1, 2018: Since the merger has not been completed, we have further extended the closing date for this deal to June 30, 2018.

May 18, 2018: Fresenius SE's chief executive defended the company's decision to pull out of a planned $4.8 billion takeover of Akorn (AKRX), saying it was the only option after uncovering data integrity breaches at the U.S drugmaker.

July 2, 2018: Since the merger has not been completed, we have further extended the closing date for this deal to July 31, 2018.

August 1, 2018: Akorn (AKRX) expects to receive the Court’s ruling after the post-trial hearing, which is scheduled for August 23, 2018. Following expedited discovery, from July 9 to 13, 2018, the Court of Chancery held a trial on the parties’ claims (collectively, the “Delaware Action”). At the conclusion of trial, the Court of Chancery ordered post-trial briefing, which is scheduled to be completed on August 20, 2018. We have extended the closing date for this deal to September 30, 2018.

SCG chart 01/03/2018 Dominion Energy, Inc. (D) Stock $14.6 billion $48.00 $38.50 728,999 Yes 6.36% 12/31/2018 24.68% 66.72%
SCANA Corporation merger details:

Expected to close in 2018 for a closing value of $14.6 billion in an all stock deal. Under the terms of the agreement, SCANA shareholders would receive 0.6690 shares of Dominion Energy common stock for each share of SCANA common stock.

Update(s)

February 1, 2018: Dominion Energy (D), and SCANA Corporation (SCG) announced that their proposed combination has cleared a key condition needed for completion. The Federal Trade Commission has granted early termination of the 30-day waiting period under the federal Hart-Scott-Rodino Antitrust Improvements Act with regard to the combination.

March 21, 2018: The Georgia Public Service Commission unanimously approved the merger of Dominion Energy (D), and SCANA Corporation (SCG).

April 19, 2018: According to Bloomberg, Dominion Energy’s (D) takeover of Scana (SCG) is looking even less likely to happen, or less likely on the current terms, after a bill passed by South Carolina legislators late Wednesday. The state Senate voted to cut the money Scana can collect from customers for a half-finished nuclear power project the company scrapped last year. 

July 13, 2018: The proposed merger of Dominion Energy (D) and SCANA Corporation (SCG) achieved another significant milestone with the approval of the Federal Energy Regulatory Commission (FERC).

July 31, 2018: The proposed combination of Dominion Energy (D) and SCANA Corporation (SCG) achieved another significant milestone with the approval of SCANA's shareholders.  

According to Bloomberg, Dominion Energy’s $7.9 billion takeover of Scana (SCG) is looking even less likely to happen, or less likely on the current terms, after a bill passed by South Carolina legislators late Wednesday. The state Senate voted to cut the money Scana can collect from customers for a half-finished nuclear power project the company scrapped last year. According to Bloomberg, Dominion Energy’s $7.9 billion takeover of Scana (SCG) is looking even less likely to happen, or less likely on the current terms, after a bill passed by South Carolina legislators late Wednesday. The state Senate voted to cut the money Scana can collect from customers for a half-finished nuclear power project the company scrapped last year. 
GNW chart 10/23/2016 China Oceanwide Holdings Group Co., Ltd. (N/A) Cash $2.7 billion $5.43 $4.52 4,735,005 Yes N/A 12/01/2018 20.13% 69.99%
Genworth Financial, Inc. merger details:

Expected to close in the middle of 2017 for a closing value of $2.7 billion. Upon completion of the merger, shareholders of Genworth Financial will receive $5.43 per share in cash.

Update(s)

December 21, 2016: Genworth Financial (GNW) announced that under the HSR Act, the merger with China Oceanwide Holdings Group may not be completed until certain information and materials have been provided by Asia Pacific and Genworth to the Antitrust Division of the U.S. Department of Justice and the Federal Trade Commission, and the applicable waiting period under the HSR Act has expired or been terminated. The parties filed the required notifications with the Antitrust Division and the FTC on December 7, 2016 and early termination of the applicable waiting period was granted on December 16, 2016.

January 25, 2017: Genworth Financial (GNW) announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission and will commence mailing to stockholders of record the definitive proxy materials in connection with the previously announced transaction with China Oceanwide Holdings Group. The special meeting of Genworth stockholders will be held on Tuesday, March 7, 2017.

March 7, 2017: Genworth Financial (GNW) announced that at its stockholders adopted the previously announced merger agreement with China Oceanwide Holdings Group.

April 29, 2017: China Oceanwide Holdings Group said that it had refiled its application for U.S. approval of its $2.7 billion acquisition of life insurance company Genworth Financial (GNW), in a bid to add more time to the regulatory review.

July 13, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group reported that they have withdrawn and re-filed their joint voluntary notice with the Committee on Foreign Investment in the United States (CFIUS) a second time to provide CFIUS more time to review and discuss the proposed transaction between Genworth and Oceanwide.

August 2, 2017: Genworth (GNW) and Oceanwide continue to work diligently to satisfy the closing conditions under their previously announced proposed transaction and are committed to closing the transaction as soon as possible. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of required regulatory approvals in the U.S., China, and other international jurisdictions and other closing conditions. Because the timing of the regulatory reviews will delay the completion of the transaction beyond the originally targeted time frame of the middle of 2017, Genworth and Oceanwide have agreed in principle to extend the August 31, 2017, deadline set forth in the merger agreement to November 30, 2017.

September 19, 2017: China's Oceanwide Holdings is aiming to close its $2.7 billion acquisition of U.S. insurer Genworth Financial (GNW) by end of this year after securing approval from a U.S. government panel, said an executive of the Chinese firm.

October 2, 2017: A.M. Best commented that the Long-Term Issuer Credit Ratings of “bb-” of Genworth Financial (GNW) and Genworth Holdings as well as their existing Long-Term Issue Credit Ratings will remain under review with negative implications following the announcement that Genworth and China Oceanwide Holdings Group  have withdrawn their joint voluntary notice with the Committee on Foreign Investment in the United States (CFIUS).

October 4, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that the North Carolina Department of Insurance has approved the proposed acquisition of control by Oceanwide of Genworth's North Carolina-domiciled insurance companies, including Genworth Mortgage Insurance Corporation, as contemplated under the merger agreement entered into by Genworth and Oceanwide.

October 9, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that the South Carolina Department of Insurance has approved the proposed acquisition of control by Oceanwide of Genworth's South Carolina-domiciled special purpose financial captive insurance subsidiary, Rivermont Life Insurance Company I, as contemplated under the merger agreement.

November 29, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that they have agreed to a second waiver and agreement of each party’s right to terminate the previously announced merger agreement. The second waiver and agreement extends the previous deadline of Nov. 30, 2017, to April 1, 2018, and allows additional time for regulatory reviews of the transaction.

January 4, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group issued an update on the status of their efforts to obtain clearance of their proposed transaction from CFIUS. There can be no assurances that CFIUS will ultimately agree to clear a transaction between Genworth and Oceanwide on terms acceptable to the parties or at all. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of state-level regulatory approvals that are pending in Delaware and New York, as well as regulatory reviews in China and other international jurisdictions and other closing conditions. 

February 6, 2018: Genworth Financial (GNW) said that its application for assent to a takeover by China Oceanwide Holdings Group had been refiled, after agreeing changes the duo hope will alleviate U.S. regulatory concerns.

March 27, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group announced they have agreed to a fourth waiver and agreement of each party’s right to terminate the previously announced merger agreement. The fourth waiver and agreement extends the previous deadline of April 1, 2018 to July 1, 2018, and allows additional time for regulatory reviews of the transaction.

April 24, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group reported that they have withdrawn and re-filed their joint voluntary notice with the Committee on Foreign Investment in the United States (CFIUS) to provide CFIUS additional time to review and discuss the proposed transaction between Genworth and Oceanwide.

June 9, 2018: China Oceanwide Holdings Group and Genworth Financial (GNW) announced that the Committee on Foreign Investment in the United States (CFIUS) has completed its review of their proposed transaction and concluded that there are no unresolved national security concerns with respect to the proposed transaction. The closing of the transaction remains subject to other conditions, including the receipt of required regulatory approvals in the U.S., China and other international jurisdictions. 

June 28, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group announced they have agreed to a fifth waiver and agreement of each party’s right to terminate the previously announced merger agreement. The fifth waiver and agreement extends the previous deadline of July 1, 2018 to August 15, 2018 to allow additional time for continued regulatory review of the transaction.

August 14, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that they have agreed to a sixth waiver and agreement of each party's right to terminate the previously announced merger agreement. The sixth waiver and agreement extends the previous deadline of August 15, 2018 to December 1, 2018 to allow additional time to complete the regulatory review process.

Genworth and Oceanwide continue to work diligently to satisfy the closing conditions under their previously announced proposed transaction and are committed to closing the transaction as soon as possible. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of required regulatory approvals in the U.S., China, and other international jurisdictions and other closing conditions. Because the timing of the regulatory reviews will delay the completion of the transaction beyond the originally targeted time frame of the middle of 2017, Genworth and Oceanwide have agreed in principle to extend the August 31, 2017, deadline set forth in the merger agreement to November 30, 2017.Genworth and Oceanwide continue to work diligently to satisfy the closing conditions under their previously announced proposed transaction and are committed to closing the transaction as soon as possible. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of required regulatory approvals in the U.S., China, and other international jurisdictions and other closing conditions. Because the timing of the regulatory reviews will delay the completion of the transaction beyond the originally targeted time frame of the middle of 2017, Genworth and Oceanwide have agreed in principle to extend the August 31, 2017, deadline set forth in the merger agreement to November 30, 2017.
SHPG chart 05/08/2018 Takeda Pharmaceutical Company Limited (TKPYY) Special Conditions $77.78 billion $194.74 $170.42 518,503 Yes 1.05% 06/30/2019 14.27% 16.48%
Shire plc merger details:

Expected to close in the first half of 2019 for a closing value of $77.78 billion. Under the terms of the acquisition, Shire shareholders will be entitled to receive, for each Shire share, $30.33 in cash and either 0.839 new Takeda shares or 1.678 Takeda ADSs. We have used $20.61 as the price for the Takeda ADS and multiplied it by 1.678 for the stock portion of the deal.

Update(s)

July 10, 2018: Takeda Pharmaceutical said it has received U.S. approval for its acquisition of London-listed Shire (SHPG). The drugmaker expects the deal to close in the first half of 2019.

RSYS chart 07/02/2018 Reliance Industries Limited (N/A) Cash $100.94 million $1.72 $1.51 84,563 N/A N/A 12/31/2018 13.91% 37.60%
Radisys Corporation merger details:

Expected to close by the end of 2018 for a closing value of $100.94 million. Upon completion of the merger, shareholders of Radisys Corporation will receive $1.72 per share in cash.

STC chart 03/16/2018 Fidelity National Financial, Inc. (FNF) Cash Plus Stock $1.2 billion $50.66 $44.63 78,605 Yes 2.69% 06/30/2019 13.51% 15.61%
Stewart Information Services Corporation merger details:

Expected to close in the first or second quarter of 2019 for a closing value of $1.2 billion in a cash plus stock deal. Under the terms of the agreement, Stewart shareholders will receive $25.00 in cash and 0.6425 common shares of Fidelity for each share of Stewart common stock they hold at closing.

Note: Premium members can sort this table by Symbol, Profit, Annualized Profit and Closing Date. Desktop Version

  Symbol Clo. Date Profit Annu. Profit
AKRX chart 09/30/2018 79.04% 670.93%
Akorn, Inc. merger details:

Expected to close by early 2018 for a closing value of $4.75 billion. Upon completion of the merger, shareholders of Akorn will receive $34.00 per share in cash.

Update(s)

July 19, 2017: Akorn (AKRX) announced that its shareholders, at a special meeting, have overwhelmingly voted to approve the previously announced merger agreement providing for the acquisition of Akorn by Fresenius Kabi.

February 27, 2018: According to Reuters, German healthcare group Fresenius SE has raised doubts about its planned acquisition of Akorn (AKRX) because of a probe into data integrity at the U.S. maker of liquid generic drugs.

March 31, 2018: In Akorn's (AKRX) 10K filed on February 28, 2018, it is mentioned that the merger may not be completed in a timely manner or at all. Since the deal did not close as scheduled on March 31, 2018, we have extended the closing date for this deal to April 30, 2018.

April 22, 2018: According to Bloomberg, Fresenius SE said it’s terminating the acquisition of Akorn (AKRX) after finding what it calls data-integrity issues at the U.S.-based generic-drug company.

April 23, 2018: Akorn (AKRX) filed a complaint in Delaware Chancery Court asking that Fresenius Kabi AG be required to fulfill its obligations under the definitive merger agreement.

May 1, 2018: Since the merger has not been completed, we have further extended the closing date for this deal to June 30, 2018.

May 18, 2018: Fresenius SE's chief executive defended the company's decision to pull out of a planned $4.8 billion takeover of Akorn (AKRX), saying it was the only option after uncovering data integrity breaches at the U.S drugmaker.

July 2, 2018: Since the merger has not been completed, we have further extended the closing date for this deal to July 31, 2018.

August 1, 2018: Akorn (AKRX) expects to receive the Court’s ruling after the post-trial hearing, which is scheduled for August 23, 2018. Following expedited discovery, from July 9 to 13, 2018, the Court of Chancery held a trial on the parties’ claims (collectively, the “Delaware Action”). At the conclusion of trial, the Court of Chancery ordered post-trial briefing, which is scheduled to be completed on August 20, 2018. We have extended the closing date for this deal to September 30, 2018.

SCG chart 12/31/2018 24.68% 66.72%
SCANA Corporation merger details:

Expected to close in 2018 for a closing value of $14.6 billion in an all stock deal. Under the terms of the agreement, SCANA shareholders would receive 0.6690 shares of Dominion Energy common stock for each share of SCANA common stock.

Update(s)

February 1, 2018: Dominion Energy (D), and SCANA Corporation (SCG) announced that their proposed combination has cleared a key condition needed for completion. The Federal Trade Commission has granted early termination of the 30-day waiting period under the federal Hart-Scott-Rodino Antitrust Improvements Act with regard to the combination.

March 21, 2018: The Georgia Public Service Commission unanimously approved the merger of Dominion Energy (D), and SCANA Corporation (SCG).

April 19, 2018: According to Bloomberg, Dominion Energy’s (D) takeover of Scana (SCG) is looking even less likely to happen, or less likely on the current terms, after a bill passed by South Carolina legislators late Wednesday. The state Senate voted to cut the money Scana can collect from customers for a half-finished nuclear power project the company scrapped last year. 

July 13, 2018: The proposed merger of Dominion Energy (D) and SCANA Corporation (SCG) achieved another significant milestone with the approval of the Federal Energy Regulatory Commission (FERC).

July 31, 2018: The proposed combination of Dominion Energy (D) and SCANA Corporation (SCG) achieved another significant milestone with the approval of SCANA's shareholders.  

According to Bloomberg, Dominion Energy’s $7.9 billion takeover of Scana (SCG) is looking even less likely to happen, or less likely on the current terms, after a bill passed by South Carolina legislators late Wednesday. The state Senate voted to cut the money Scana can collect from customers for a half-finished nuclear power project the company scrapped last year. According to Bloomberg, Dominion Energy’s $7.9 billion takeover of Scana (SCG) is looking even less likely to happen, or less likely on the current terms, after a bill passed by South Carolina legislators late Wednesday. The state Senate voted to cut the money Scana can collect from customers for a half-finished nuclear power project the company scrapped last year. 
GNW chart 12/01/2018 20.13% 69.99%
Genworth Financial, Inc. merger details:

Expected to close in the middle of 2017 for a closing value of $2.7 billion. Upon completion of the merger, shareholders of Genworth Financial will receive $5.43 per share in cash.

Update(s)

December 21, 2016: Genworth Financial (GNW) announced that under the HSR Act, the merger with China Oceanwide Holdings Group may not be completed until certain information and materials have been provided by Asia Pacific and Genworth to the Antitrust Division of the U.S. Department of Justice and the Federal Trade Commission, and the applicable waiting period under the HSR Act has expired or been terminated. The parties filed the required notifications with the Antitrust Division and the FTC on December 7, 2016 and early termination of the applicable waiting period was granted on December 16, 2016.

January 25, 2017: Genworth Financial (GNW) announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission and will commence mailing to stockholders of record the definitive proxy materials in connection with the previously announced transaction with China Oceanwide Holdings Group. The special meeting of Genworth stockholders will be held on Tuesday, March 7, 2017.

March 7, 2017: Genworth Financial (GNW) announced that at its stockholders adopted the previously announced merger agreement with China Oceanwide Holdings Group.

April 29, 2017: China Oceanwide Holdings Group said that it had refiled its application for U.S. approval of its $2.7 billion acquisition of life insurance company Genworth Financial (GNW), in a bid to add more time to the regulatory review.

July 13, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group reported that they have withdrawn and re-filed their joint voluntary notice with the Committee on Foreign Investment in the United States (CFIUS) a second time to provide CFIUS more time to review and discuss the proposed transaction between Genworth and Oceanwide.

August 2, 2017: Genworth (GNW) and Oceanwide continue to work diligently to satisfy the closing conditions under their previously announced proposed transaction and are committed to closing the transaction as soon as possible. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of required regulatory approvals in the U.S., China, and other international jurisdictions and other closing conditions. Because the timing of the regulatory reviews will delay the completion of the transaction beyond the originally targeted time frame of the middle of 2017, Genworth and Oceanwide have agreed in principle to extend the August 31, 2017, deadline set forth in the merger agreement to November 30, 2017.

September 19, 2017: China's Oceanwide Holdings is aiming to close its $2.7 billion acquisition of U.S. insurer Genworth Financial (GNW) by end of this year after securing approval from a U.S. government panel, said an executive of the Chinese firm.

October 2, 2017: A.M. Best commented that the Long-Term Issuer Credit Ratings of “bb-” of Genworth Financial (GNW) and Genworth Holdings as well as their existing Long-Term Issue Credit Ratings will remain under review with negative implications following the announcement that Genworth and China Oceanwide Holdings Group  have withdrawn their joint voluntary notice with the Committee on Foreign Investment in the United States (CFIUS).

October 4, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that the North Carolina Department of Insurance has approved the proposed acquisition of control by Oceanwide of Genworth's North Carolina-domiciled insurance companies, including Genworth Mortgage Insurance Corporation, as contemplated under the merger agreement entered into by Genworth and Oceanwide.

October 9, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that the South Carolina Department of Insurance has approved the proposed acquisition of control by Oceanwide of Genworth's South Carolina-domiciled special purpose financial captive insurance subsidiary, Rivermont Life Insurance Company I, as contemplated under the merger agreement.

November 29, 2017: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that they have agreed to a second waiver and agreement of each party’s right to terminate the previously announced merger agreement. The second waiver and agreement extends the previous deadline of Nov. 30, 2017, to April 1, 2018, and allows additional time for regulatory reviews of the transaction.

January 4, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group issued an update on the status of their efforts to obtain clearance of their proposed transaction from CFIUS. There can be no assurances that CFIUS will ultimately agree to clear a transaction between Genworth and Oceanwide on terms acceptable to the parties or at all. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of state-level regulatory approvals that are pending in Delaware and New York, as well as regulatory reviews in China and other international jurisdictions and other closing conditions. 

February 6, 2018: Genworth Financial (GNW) said that its application for assent to a takeover by China Oceanwide Holdings Group had been refiled, after agreeing changes the duo hope will alleviate U.S. regulatory concerns.

March 27, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group announced they have agreed to a fourth waiver and agreement of each party’s right to terminate the previously announced merger agreement. The fourth waiver and agreement extends the previous deadline of April 1, 2018 to July 1, 2018, and allows additional time for regulatory reviews of the transaction.

April 24, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group reported that they have withdrawn and re-filed their joint voluntary notice with the Committee on Foreign Investment in the United States (CFIUS) to provide CFIUS additional time to review and discuss the proposed transaction between Genworth and Oceanwide.

June 9, 2018: China Oceanwide Holdings Group and Genworth Financial (GNW) announced that the Committee on Foreign Investment in the United States (CFIUS) has completed its review of their proposed transaction and concluded that there are no unresolved national security concerns with respect to the proposed transaction. The closing of the transaction remains subject to other conditions, including the receipt of required regulatory approvals in the U.S., China and other international jurisdictions. 

June 28, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group announced they have agreed to a fifth waiver and agreement of each party’s right to terminate the previously announced merger agreement. The fifth waiver and agreement extends the previous deadline of July 1, 2018 to August 15, 2018 to allow additional time for continued regulatory review of the transaction.

August 14, 2018: Genworth Financial (GNW) and China Oceanwide Holdings Group announced that they have agreed to a sixth waiver and agreement of each party's right to terminate the previously announced merger agreement. The sixth waiver and agreement extends the previous deadline of August 15, 2018 to December 1, 2018 to allow additional time to complete the regulatory review process.

Genworth and Oceanwide continue to work diligently to satisfy the closing conditions under their previously announced proposed transaction and are committed to closing the transaction as soon as possible. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of required regulatory approvals in the U.S., China, and other international jurisdictions and other closing conditions. Because the timing of the regulatory reviews will delay the completion of the transaction beyond the originally targeted time frame of the middle of 2017, Genworth and Oceanwide have agreed in principle to extend the August 31, 2017, deadline set forth in the merger agreement to November 30, 2017.Genworth and Oceanwide continue to work diligently to satisfy the closing conditions under their previously announced proposed transaction and are committed to closing the transaction as soon as possible. In addition to clearance by CFIUS, the closing of the proposed transaction remains subject to the receipt of required regulatory approvals in the U.S., China, and other international jurisdictions and other closing conditions. Because the timing of the regulatory reviews will delay the completion of the transaction beyond the originally targeted time frame of the middle of 2017, Genworth and Oceanwide have agreed in principle to extend the August 31, 2017, deadline set forth in the merger agreement to November 30, 2017.
SHPG chart 06/30/2019 14.27% 16.48%
Shire plc merger details:

Expected to close in the first half of 2019 for a closing value of $77.78 billion. Under the terms of the acquisition, Shire shareholders will be entitled to receive, for each Shire share, $30.33 in cash and either 0.839 new Takeda shares or 1.678 Takeda ADSs. We have used $20.61 as the price for the Takeda ADS and multiplied it by 1.678 for the stock portion of the deal.

Update(s)

July 10, 2018: Takeda Pharmaceutical said it has received U.S. approval for its acquisition of London-listed Shire (SHPG). The drugmaker expects the deal to close in the first half of 2019.

RSYS chart 12/31/2018 13.91% 37.60%
Radisys Corporation merger details:

Expected to close by the end of 2018 for a closing value of $100.94 million. Upon completion of the merger, shareholders of Radisys Corporation will receive $1.72 per share in cash.

STC chart 06/30/2019 13.51% 15.61%
Stewart Information Services Corporation merger details:

Expected to close in the first or second quarter of 2019 for a closing value of $1.2 billion in a cash plus stock deal. Under the terms of the agreement, Stewart shareholders will receive $25.00 in cash and 0.6425 common shares of Fidelity for each share of Stewart common stock they hold at closing.

Only premium members can access all active mergers and acquisitions. Subscribe today.